Wagner A, Blunk J A, Benrath J
Schmerzzentrum der Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland.
HNO. 2011 Jul;59(7):656-63. doi: 10.1007/s00106-011-2269-0.
Cancer pain in the field of otolaryngology can be effectively alleviated. Only very few questions regarding the patient's history of pain are required to understand the type of pain being dealt with and to be able to make the correct selection of analgetic agents. It is particularly important to treat tumor breakthrough pain appropriately, for which a sufficient number of therapeutic agents are available. The present article comments on the various possibilities of specific drugs and interventional therapeutic approaches, as well as their specific characteristics within the field of otolaryngology, supplemented with various tricks for their practical application. Using these basic rules, most problems can be identified and specific treatments optimized. The progression of cancer pain may show wide dynamic ranges, and the therapeutic approach should always be adjusted to the current situation. Palliative care of a cancer patient may be particularly challenging in that, not only the treatment of pain, but also the treatment of respiratory distress is of key importance.
耳鼻喉科领域的癌痛能够得到有效缓解。只需询问患者极少关于疼痛病史的问题，就能了解所处理疼痛的类型，并能够正确选择止痛药物。恰当治疗肿瘤突破性疼痛尤为重要，针对这种疼痛有足够数量的治疗药物可供使用。本文评论了特定药物和介入性治疗方法的各种可能性，以及它们在耳鼻喉科领域的具体特点，并补充了其实际应用的各种技巧。运用这些基本规则，大多数问题能够被识别出来，具体治疗也能得到优化。癌痛的进展可能呈现出广泛的动态范围，治疗方法应始终根据当前情况进行调整。癌症患者的姑息治疗可能特别具有挑战性，因为不仅疼痛治疗，呼吸窘迫的治疗也至关重要。
